✦ LIBER ✦

Safety and Pharmacokinetics of Facilitated-Subcutaneous Infusion of Immune Globulin (Human), 10% and Recombinant Human Hyaluronidase (IGHy) in a Phase III Extension Study in Patients With Primary Immunodeficiency Disease (PIDD)

✍ Scribed by Melamed, I.; Wasserman, R.L.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H.; Gelmont, D.; Schiff, R.I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability and Efficacy of Facilitated

✍ Wasserman, R.L.; Melamed, I.; Stein, M.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Long-Term Tolerability and Safety Of Fac

✍ Melamed, Isaac Reuven; Wasserman, Richard L.; Stein, Mark; Rubinstein, Arye; Puc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Pharmacokinetics (PK) of Human Immunoglo

✍ Stein, M.; Wasserman, R.L.; Melamed, I.; Puck, J.; Gupta, S.; Engl, W.; Leibl, H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Pharmacokinetics and safety of subcutane

✍ R. L. Wasserman; A.-M. Irani; J. Tracy; C. Tsoukas; D. Stark; R. Levy; J. Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

Pharmacokinetics and Safety of Subcutane

✍ Levy, R.; Chen, J.; Roberts, R.; Sorrells, S.; Stark, D.; Tracy, J.; Wasserman, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB